Why does drug resistance readily evolve but vaccine resistance does not?
Level 5 - mechanism / opinion, no new human data
Mechanism-based reasoning and evolutionary theory synthesis without original empirical data or systematic review.
PubMed 28356449 · doi:10.1098/rspb.2016.2562
What was done
Theoretical synthesis using population genetics and evolutionary ecology principles to analyze why pathogen resistance emerges readily against antimicrobial drugs but rarely against vaccines.
What was found
The abstract reports no quantitative measurements or experimental data. It outlines two primary mechanistic distinctions: vaccines generally act prophylactically (reducing pathogen load and replication potential early) and induce polyclonal immune responses against multiple pathogen epitopes, whereas drugs typically act therapeutically during high pathogen burdens and target very few specific sites. These factors reduce the generation of genetic variation and the strength of selection for vaccine escape.
Why it matters
Explains the fundamental evolutionary basis for the long-term durability of vaccines compared to therapeutic drugs, offering a framework to anticipate and identify which vaccines might be vulnerable to resistance.
Limits
The abstract describes a conceptual, narrative framework rather than a systematic review or empirical experimental study. It provides no empirical data, statistical models, or sample counts, and acknowledges that vaccine resistance can still emerge when these standard conditions are violated.
Cited by
- supports There are no documented examples in the scientific literature of human vaccines driving the evolution of a more virulent viral strain.